This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Nbe-Therapeutics Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Salvatore Di Girolamo: Innovator in Bioconjugation Technologies
Introduction
Salvatore Di Girolamo is an accomplished inventor based in Basel, Switzerland. He is currently associated with NBE-Therapeutics AG, where he focuses on innovative bioconjugation methods. Although he has not yet been granted any patents, his work is significant in the field of biotechnology.
Latest Patent Applications
Salvatore Di Girolamo's notable patent application is titled "Sortase F and Its Use in Methods for Conjugation." This invention relates to a method for producing a conjugate of two substrates. The method involves providing two substrates, each selected from groups consisting of small molecules and proteins. The enzymatic conjugation of the two substrates is achieved using a sortase F enzyme or a catalytic domain thereof. One substrate contains a sortase F recognition motif, while the other substrate includes at least one motif selected from a Glymotif, an Alamotif, or a mixture of Ala and Gly residues. The reaction occurs in an aqueous medium with a salt concentration ranging from about 0.01 to 3 M, resulting in a conjugated product of the two substrates.
Conclusion
Salvatore Di Girolamo is a promising inventor whose work in bioconjugation technologies has the potential to advance the field significantly. His innovative approaches may lead to new applications in biotechnology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile